Pharmaceutical Supply Chain

Jun 22, 2022  |  Director's Blog

Supply Chain Resiliency and the Role of Public-Private Collaboration: Results from an FDA Panel

I recently facilitated an FDA panel that focused on creating a resilient supply chain for the medical devices industry.  The virtual panel, Building Medical Device Supply Chain Resilience: A Healthcare and Public Health Ecosystem-Wide Collaboration, featured a number of speakers […]

Mar 9, 2021  |  Director's Blog

Challenges and Opportunities to Expand the COVID19 Vaccine Supply Chain: A Global Summit

Over the last two days, I had the honor of attending a virtual C19 Global Supply Chain and Manufacturing Summit, hosted by COVAX, CEPI, DCVMN, IFPMA, and BIO.  The speakers included a critical number of major vaccine manufacturers, suppliers, government […]

Nov 28, 2020  |  Director's Blog

During the Covid Crisis, don’t forget the Opioid Crisis

This week in a remotely conducted hearing in federal court in New Jersey, Purdue Pharma’s chairman, Steve Miller, acknowledged  that in order to meet sales goals, the company told the Drug Enforcement Administration that it had created a program to […]

Nov 5, 2019  |  Director's Blog

FDA Warns of Significant Drug Shortages – What Gives?

In a recent report, the FDA has warned of significant drug shortages in the U.S. These shortages are affecting approximately 130 drugs that are commonly used in the treatment of medical conditions or used in surgical procedures. The report titled […]

Apr 1, 2019  |  Director's Blog

Risk Management in Contract Pharmaceutical Development: Contract Research Part 2

The second installation in our series on contract management research published by MBA students from my online Contract Management class is by Julia Condit, and focuses on the challenges of managing contracts in the pharmaceutical industry.  As pharmaceutical companies go […]

Nov 20, 2018  |  Director's Blog

SCRC Research on Drug Shortages: Lawsuits, Low Cost Countries, and Litigation

Recent articles have started to highlight the number of drug shortages occurring in retail channels.  Not surprisingly, these are often related to supply chains – a topic that I have written extensively about in my books on Pharmaceutical Distribution and […]

Aug 24, 2018  |  Articles

New MBA Healthcare Analytics Class Takes Off This Fall

Healthcare providers are facing continued lower operating margins, increased risks and potentially once-in-a-lifetime health care reform.  With this backdrop, there is an increasing focus on Supply Chain Management as a means to minimize risk, optimize operating costs, improve revenue, improve […]

Feb 13, 2018  |  Director's Blog

Walgreen’s Acquisition of Amerisource Bergen is based on the need for integration to survive

The news of Walgreen’s potential acquisition of Amerisource Bergen is one of a string of recent announcements that signify efforts by channel players in the massive life sciences market to set up barriers to competition against behemoths by the likes […]

Oct 18, 2017  |  Director's Blog

Leadership Personified: Ken Frazier, CEO of Merck

I had the opportunity to hear Ken Frazier, CEO of Merck,  speak at the SC50 meeting.   Ken was a single child raised by a single father in Philadelphia, making his way into Harvard Law eventually.  Prior to becoming CEO, Ken […]

May 29, 2017  |  Director's Blog

SCRC Executive Roundtable: Combating Counterfeit in the Supply Chain

This week the Supply Chain Resource Cooperative is holding an executive panel focused on the challenges of dealing with counterfeiting in the supply chain.  We will be hosting a number of major public and private sector participants including the Air Force, the […]